Alcon (MEX:ALC N) Total Equity: MXN399,118 Mil (As of Mar. 2026)


MEX:ALC N Alcon Inc MEX:ALC N
73 GF Score
Price MXN1,158.62
GF Value MXN1,750.95
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Alcon Total Equity?

Alcon MEX:ALC N 73 Total Equity is MXN399,118 Mil as of Mar. 2026. GuruFocus rates MEX:ALC N with a GF Score™ of 73/100 and a GF Value™ of MXN1,750.95 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Alcon's total equity for the quarter that ended in Mar. 2026 was MXN399,118 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Alcon Total Equity Historical Data

* Premium members only.

The historical data trend for Alcon's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alcon Total Equity Chart

Alcon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 395,017.58 383,622.79 350,076.89 449,085.79 396,395.49

Alcon Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 450,469.11 416,690.20 405,186.69 396,395.49 399,117.75
MEX:ALC N
73GF Score
Alcon Inc MEX:ALC N
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alcon Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Alcon's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=568169.864-568169.864
=0

Alcon's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=570175.942-171058.192
=399,118

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of MXN399,118 Mil mean?
Alcon (MEX:ALC N) has a Total Equity of MXN399,118 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Alcon and its competitors.
Is Alcon's Total Equity too high?
Alcon's current Total Equity is MXN399,118 Mil. Overall, Alcon has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alcon's Total Equity compare to ISRG and BDX?
Alcon's Total Equity of MXN399,118 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Alcon and its competitors. Alcon's current Total Equity is MXN399,118 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcon stock overvalued right now?
Based on GuruFocus' analysis, Alcon (MEX:ALC N) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,750.95, compared to a current price of MXN1,158.62 — trading 33.8% below its estimated fair value. The current Total Equity is MXN399,118 Mil. Alcon's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Alcon (MEX:ALC N), the current Total Equity is MXN399,118 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alcon (MEX:ALC N) Overvalued in 2026?

Based on GuruFocus' analysis, Alcon stock appears to be undervalued. The current stock price of MXN1,158.62 is trading 33.8% below its estimated GF Value™ of MXN1,750.95. GuruFocus considers Alcon to be Significantly Undervalued.

Key valuation signals for MEX:ALC N:

  • Total Equity: MXN399,118 Mil
  • GF Value™: MXN1,750.95 vs. price of MXN1,158.62 (33.8% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the MEX:ALC N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alcon Business Description

Address Chemin de Blandonnet 8, Vernier, Geneva, CHE, 1214
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
73GF Score

Get the complete analysis for MEX:ALC N

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,158.62
Price
MXN1,750.95
GF Value